10 Jun, 2021 Investor interest in Alzheimer’s ‘changed on the dime’ following FDA’s decision on Biogen’s aducanumab alzheon2024-07-29T15:38:07-04:00June 10th, 2021|Tags: Fierce Biotech| Read More
